The identification of prognostic biomarkers involves a combination of clinical studies and advanced analytical techniques. High-throughput technologies like genomics, proteomics, and metabolomics are often employed. These methods enable the comprehensive analysis of biological samples to discover potential biomarkers that correlate with disease outcomes.
